FBTTX Holdings Information

FBTTX is a mutual fund with a total of 131 individual holdings. The top holdings are AbbVie stock at 13.83%, Gilead Sciences at 6.02%, Alnylam Pharmaceuticals at 3.84%, Insmed at 3.41%, and Amylyx Pharmaceuticals at 3.38%.

Total Holdings

131

Top 10 Percentage

46.21%

Asset Class

Equity

Fund Category

Health

Assets

2.35B

Forward PE Ratio

n/a

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	13.83%	1,309,480
2	GILD	Gilead Sciences, Inc.	6.02%	999,300
3	ALNY	Alnylam Pharmaceuticals, Inc.	3.84%	387,186
4	INSM	Insmed Incorporated	3.41%	680,300
5	AMLX	Amylyx Pharmaceuticals, Inc.	3.38%	2,433,200
6	ARGX	argenx SE	3.28%	77,200
7	DNTH	Dianthus Therapeutics, Inc.	3.18%	730,062
8	SYRE	Spyre Therapeutics, Inc.	3.16%	857,347
9	MRNA	Moderna, Inc.	3.12%	540,500
10	RVMD	Revolution Medicines, Inc.	2.98%	352,200
11	ASND	Ascendis Pharma A/S	2.92%	269,225
12	ORKA	Oruka Therapeutics, Inc.	2.81%	737,386
13	COGT	Cogent Biosciences, Inc.	2.65%	1,834,818
14	BIIB	Biogen Inc.	2.62%	294,100
15	AMGN	Amgen Inc.	2.39%	135,103
16	MBX	MBX Biosciences, Inc.	2.07%	817,600
17	PCVX	Vaxcyte, Inc.	2.01%	801,529
18	NTRA	Natera, Inc.	1.96%	147,500
19	VRDN	Viridian Therapeutics, Inc.	1.70%	1,782,464
20	VRTX	Vertex Pharmaceuticals Incorporated	1.43%	63,900
21	n/a	Fidelity Cash Central Fund	1.42%	34,539,522
22	RLAY	Relay Therapeutics, Inc.	1.40%	1,850,700
23	KNSA	Kiniksa Pharmaceuticals International, plc	1.35%	417,600
24	ELVN	Enliven Therapeutics, Inc.	1.20%	501,368
25	KYMR	Kymera Therapeutics, Inc.	1.13%	231,700

Showing 25 of 131 holdings

Subscribe to see the full list

Activate Now

As of Aug 31, 2026